Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Receivables (2017 - 2021)

Creative Medical Technology Holdings (CELZ) has disclosed Receivables for 5 consecutive years, with $2485.0 as the latest value for Q4 2021.

  • On a quarterly basis, Receivables changed N/A to $2485.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $2485.0, a N/A change, with the full-year FY2021 number at $2485.0, changed N/A from a year prior.
  • Receivables was $2485.0 for Q4 2021 at Creative Medical Technology Holdings, up from $1400.0 in the prior quarter.
  • In the past five years, Receivables ranged from a high of $24500.0 in Q3 2019 to a low of $163.0 in Q1 2019.
  • A 5-year average of $7195.8 and a median of $5200.5 in 2017 define the central range for Receivables.
  • Peak YoY movement for Receivables: tumbled 98.3% in 2019, then skyrocketed 5053.37% in 2020.
  • Creative Medical Technology Holdings' Receivables stood at $4801.0 in 2017, then soared by 99.96% to $9600.0 in 2018, then crashed by 41.67% to $5600.0 in 2019, then plummeted by 75.0% to $1400.0 in 2020, then surged by 77.5% to $2485.0 in 2021.
  • Per Business Quant, the three most recent readings for CELZ's Receivables are $2485.0 (Q4 2021), $1400.0 (Q2 2020), and $8400.0 (Q1 2020).